Description
Nasim Shahangian
Hello Class,
Discuss the key differences in the management of type I and type II diabetes.
Bridget, a 30-year-old woman, was recently diagnosed with diabetes. After the necessary tests were conducted, it was confirmed that Bridget has type I diabetes. Her major concern is how her condition will be managed and whether she will maintain a high-quality life like before.
Management of type I diabetes usually involves insulin therapy, as the body does not produce insulin. The goal is to mimic the normal insulin secretion in the body through multiple injections or an insulin pump. Additionally, blood glucose monitoring is essential as it informs the adjustment of insulin doses. Further, meal planning is essential, and therefore, Bridget will work with a dietician to create a personalized meal plan. Lastly, physical activity is important for managing blood sugar levels. However, one should be careful to avoid hypoglycemia or hyperglycemia (Aschner et al., 2010).
For type II diabetes, medications are mostly used depending on the severity of the condition. Oral medications such as metformin, sulfonylureas, and dipeptidyl peptidase-4 (DPP-4) inhibitors improve insulin sensitivity or stimulate its production. Additionally, blood glucose should be monitored,as well as carbohydrate intake, to manage its levels. Further regular physical activity is encouraged to improve overallhealth (Borse et al., 2021).
Tailoring the treatment plan to the needs of patients with type I versus type II diabetes?
A treatment plan for type I diabetes is individualized based on factors such as age, lifestyle, occupation, and overall health. Apart from monitoring the blood sugar levels and adjusting insulin doses accordingly, education and support are crucial to ensure proper insulin administration, meal planning, and understanding the signs and symptoms of hypo and hyperglycemia. Treatment plans for type II diabetes considerage, weight, comorbidities, and patent preferences. Treatment plan focuses on lifestyle modification, and it includes the administration of oral medications.
McKenzie Rosendale
Benign Prostatic Hyperplasia (BPH) medications, such as alpha-blockers and 5-alpha reductase inhibitors, have different mechanisms of action, dosing regimens, and potential side effects. How can you ensure that the chosen medication is safe, effective, and tailored to the patient’s individual needs and preferences?
Benign prostatic hyperplasia is a condition that affects older men, typically 60 years old or greater, and is when the prostate and surrounding tissue expands. Symptoms of benign prostatic hyperplasia include urinary hesitancy, urinary urgency, increased frequency of urination, dysuria, and nocturia (Rosenthal & Burchum, 2021, pg. 463). Before prescribing medications, a thorough assessment and labs must be completed. Lab will be able to provide information regarding PSA levels and if the PSA level is elevated, which can be a sign of BPH. The provider should also review the medical history, allergies, and other medications to make sure there is no contraindications. There are two medications that are used for BPH: 5-alpha reductase inhibitors and alpha-adrenergic antagonists. Dutasteride and finasteride are two medications that are 5-alpha- reductase inhibitors and help reduce the prostate size. For alpha-adrenergic antagonists, the two medications are silodosin and tamsulosin. The mechanism of action for these medications is to block the alpha receptors to help relax the smooth muscle of the bladder neck (Rosenthal & Burchum, 2021, pg. 464). The provider can ensure safe and effective medication administration by the provider going over the side effects of the medication and educating the patient on the mechanism of the action for the medications. In addition to education, the patient should be frequently monitored for any side effects and have PSA checked more often. In conclusion, it is important that the provider tailors each treatment to focus on the patient’s needs and ensures safe and effective medication administration.